Akèy › Amiloidoz Chèn Limyè Imunoglobulin › Massachusetts
Etid klinik pou Amiloidoz Chèn Limyè Imunoglobulin nan Massachusetts
7 etid pou Amiloidoz Chèn Limyè Imunoglobulin ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Tufts Medical Center, Boston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06569147Teclistamab-Daratumumab in AL Amyloidosis
- Boston Medical Center, Boston
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Jul 13, 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Boston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Boston Medical Center, Boston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06022939Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- Boston University Cancer Research Center, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 1, 2025 · NCT00898235Molecular Imaging of Primary Amyloid Cardiomyopathy
- Brigham and Womens' Hospital, Boston
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Nov 14, 2025 · NCT02641145Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Tufts Medical Center, Boston
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT06365060Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.